Catalio Capital Management, LP 13F holdings, Q1 2025
Holdings as of March 31, 2025 · filings on SEC EDGAR · latest filing →
Catalio Capital Management, LP disclosed 35 US equity positions worth $403.4m in its Q1 2025 13F filing. The largest position was BDX at 11.6% of the reported book, followed by SWTXUSD and BBIO. Against the Q4 2024 filing, it opened 12 new positions, added to 7 and reduced 6 among the top 35 holdings.
What did Catalio Capital Management, LP own in Q1 2025? Top 35 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q4 2024 |
|---|---|---|---|---|---|---|---|
| 1 | BDX BECTON DICKINSON & CO | Healthcare | 11.6% | $46.7m | 203,965 | 37% | added |
| 2 | SWTXUSD SPRINGWORKS THERAPEUTICS INC | 8.3% | $33.5m | 758,533 | -1% | reduced | |
| 3 | BBIO BRIDGEBIO PHARMA INC | Healthcare | 8.3% | $33.3m | 962,883 | 7% | added |
| 4 | EW EDWARDS LIFESCIENCES CORP | Healthcare | 7.8% | $31.6m | 435,588 | 31% | added |
| 5 | ASND ASCENDIS PHARMA A/S | Healthcare | 7.6% | $30.5m | 195,523 | -9% | reduced |
| 6 | CYTK CYTOKINETICS INC | Healthcare | 5.8% | $23.5m | 585,812 | 28% | added |
| 7 | VCYT VERACYTE INC | Healthcare | 5.6% | $22.6m | 762,225 | 55% | added |
| 8 | SNDX SYNDAX PHARMACEUTICALS INC | Healthcare | 5.3% | $21.3m | 1,733,701 | – | new |
| 9 | LLY ELI LILLY & CO | Healthcare | 4.8% | $19.6m | 23,682 | – | new |
| 10 | ISRG INTUITIVE SURGICAL INC | Healthcare | 4.5% | $18.1m | 36,499 | -1% | reduced |
| 11 | LIVN LIVANOVA PLC | Healthcare | 3.7% | $15.0m | 381,648 | -26% | reduced |
| 12 | DNTH DIANTHUS THERAPEUTICS INC | Healthcare | 3.4% | $13.8m | 763,471 | 0% | held |
| 13 | INSP INSPIRE MED SYS INC | Healthcare | 3.4% | $13.7m | 85,877 | – | new |
| 14 | GPCR STRUCTURE THERAPEUTICS INC | Healthcare | 3.0% | $12.2m | 704,864 | 24% | added |
| 15 | SLNOEUR SOLENO THERAPEUTICS INC | 2.9% | $11.5m | 160,962 | – | new | |
| 16 | QURE UNIQURE NV | 2.2% | $8.8m | 830,325 | -8% | reduced | |
| 17 | REGN REGENERON PHARMACEUTICALS | Healthcare | 1.9% | $7.8m | 12,261 | – | new |
| 18 | SEPN SEPTERNA INC | 1.5% | $5.9m | 1,024,245 | 0% | held | |
| 19 | TARA PROTARA THERAPEUTICS INC | 1.1% | $4.6m | 1,088,691 | 0% | held | |
| 20 | ADPT ADAPTIVE BIOTECHNOLOGIES COR | Healthcare | 1.1% | $4.5m | 611,639 | – | new |
| 21 | MLTX MOONLAKE IMMUNOTHERAPEUTICS | Healthcare | 1.1% | $4.5m | 114,616 | – | new |
| 22 | KROS KEROS THERAPEUTICS INC | Healthcare | 1.0% | $4.0m | 389,384 | -4% | reduced |
| 23 | VIR VIR BIOTECHNOLOGY INC | Healthcare | 1.0% | $4.0m | 611,608 | – | new |
| 24 | REPL REPLIMUNE GROUP INC | Healthcare | 0.9% | $3.5m | 355,640 | – | new |
| 25 | ZBIO ZENAS BIOPHARMA INC | 0.6% | $2.3m | 295,148 | 58% | added | |
| 26 | OM OUTSET MED INC | 0.5% | $1.8m | 166,666 | – | new | |
| 27 | KYTX KYVERNA THERAPEUTICS INC | 0.3% | $1.1m | 586,909 | 0% | held | |
| 28 | MGX METAGENOMI INC | 0.2% | $719.4k | 528,993 | 0% | held | |
| 29 | MERSANA THERAPEUTICS INC | 0.1% | $586.9k | 1,705,036 | 0% | held | |
| 30 | FULC FULCRUM THERAPEUTICS INC | Healthcare | 0.1% | $582.2k | 202,139 | – | new |
| 31 | KPTI KARYOPHARM THERAPEUTICS INC | 0.1% | $582.0k | 155,622 | – | new | |
| 32 | HYPR HYPERFINE INC | 0.1% | $544.4k | 760,035 | 0% | held | |
| 33 | ATAI LIFE SCIENCES NV | 0.1% | $267.7k | 196,858 | 0% | held | |
| 34 | GUTS FRACTYL HEALTH INC | 0.1% | $254.9k | 214,236 | 0% | held | |
| 35 | SNSEEUR SENSEI BIOTHERAPEUTICS INC | 0.0% | $116.0k | 294,374 | 0% | held |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.